Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06734871. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07093411. IPD Sharing: NO. Countries: 1. Publications: 0.
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01540578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients
ClinicalTrials.gov study NCT03318835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region
ClinicalTrials.gov study NCT04859920. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05600686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas
ClinicalTrials.gov study NCT04407741. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05720052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma
ClinicalTrials.gov study NCT02945215. IPD Sharing: NO. Countries: 1. Publications: 0.
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03571308. IPD Sharing: NO. Countries: 1. Publications: 0.
Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
ClinicalTrials.gov study NCT03881774. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05618327. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
ClinicalTrials.gov study NCT05207670. IPD Sharing: YES. Countries: 1. Publications: 0.
Relationships of B-cell Activating Factor Gene Polymorphisms With Crohn's Disease.
ClinicalTrials.gov study NCT07387172. IPD Sharing: NO. Countries: 1. Publications: 0.
Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02051257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
ClinicalTrials.gov study NCT07205315. IPD Sharing: NO. Countries: 1. Publications: 0.
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
ClinicalTrials.gov study NCT06961669. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01982175. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01933516. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
ClinicalTrials.gov study NCT05179733. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.